Showing results for "Category/Adult/Lung disease and Asthma"
Found 3 Clinical Trial s
The purpose of the study is to learn more about how early life factors affect the development of childhood asthma and allergies.
This study intends to evaluate the safety and efficacy of ravulizumab for the treatment of COVID-19 severe pneumonia, acute lung injury or acute respiratory distress syndrome (ARDS).
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP PHASE II STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF TWO DIFFERENT DOSE REGIMENS OF IFX-1 AS ADD-ON TO STANDARD OF CARE IN SUBJECTS WITH GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA)
This clinical research study will look at an investigational study drug called IFX-1. It is being investigated for the first time in people who have granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).